Megakaryocyte colony-forming unit growth is enhanced by alemtuzumab: in vitro experiments and a case report of acquired amegakaryocytic thrombocytopenic purpura
- 20 July 2006
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 20 (9), 1618-1619
- https://doi.org/10.1038/sj.leu.2404337
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Normal hematopoiesis is maintained by activated bone marrow CD4+ T cellsBlood, 2005
- T‐cell depletion with Campath‐1H ‘in the bag’ for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft‐versus‐host disease, rapid immune constitution and improved survivalBritish Journal of Haematology, 2003
- The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantationBlood, 2001
- CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cellsBone Marrow Transplantation, 2000
- Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cellsBone Marrow Transplantation, 1997
- Effect of Campath-1H antibody on human hematopoietic progenitors in vitroBlood, 1993